Cytokine status in middle-aged men with acute coronary syndrome after coronary artery stenting

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Background. Inflammatory cytokines and growth factors are involved in various mechanisms of coronary artery disease. Clinical studies have shown the correlation between the increase in the level of proinflammatory cytokines and the severity of coronary artery disease, while the data on the role of proinflammatory interleukin IL-8 and anti-inflammatory interleukin IL-4 are contradictory.

The aim of the study is to assess the levels of proinflammatory cytokines (IL-8, TNF-α) and anti-inflammatory interleukin (IL-4) in patients with various forms of coronary artery disease who underwent coronary artery stenting.

Materials and methods. By the method of enzyme-linked immunosorbent assay, the levels of cytokines were determined in 30 patients with acute coronary syndrome who underwent primary stenting of the coronary arteries and in 24 patients with chronic coronary syndrome who had previously had myocardial infarction with stenting of an infarction-associated artery, who were admitted to the clinic for staged stenting of the coronary arteries.

Results. In patients with chronic coronary syndrome the levels of IL-4 a do not exceed the reference values, in patients with acute coronary syndrome the levels of IL-4 there was an increase 3,70 ± 0,24 and 240,85 ± 49,25 pg/ml, р ≤ 0,001. In patients with chronic coronary syndrome the levels of IL-8 a do not exceed the reference values, in patients with acute coronary syndrome the levels of IL-8 there was an increase 7,34 ± 1,29 and 110,33 ± 27,67 pg/ml, р ≤ 0,001.

Conclusion. Most likely the increase in the level of IL-4 has a compensatory character and, along with a slight increase in TNF-α, can be considered as a positive factor stabilizing the course of the disease. There may be some relationship between of the increase in the level of interleukins in patients with acute coronary syndrome on the degree of stenosis of the coronary arteries (90–95%) and impaired myocardial contractility was established.

Full Text

Restricted Access

About the authors

Vadim A. Gostimskiy

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: gostimsky@hotmail.com

Postgraduate Student

Russian Federation, Saint Petersburg

Vladimir S. Vasilenko

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: vasilenkovladi@yandex.ru

MD, PhD, Dr. Sci. (Med.), Professor

Russian Federation, Saint Petersburg

Elena A. Kurnikova

St. Petersburg State Budget Institution Health Care, City Hospital No. 26

Email: kurnikovaelena221281@yandex.ru

MD, PhD, Cand. Sci. (Med.), Head of Regional Vascular Center

Russian Federation, Saint Petersburg

Sergey V. Shenderov

St. Petersburg State Budget Institution Health Care, City Hospital No. 26

Email: S.shenderov@mail.ru

Cand. Sci. (Med.), Head of separation endovascular surgery

Russian Federation, Saint Petersburg

Ol’ga P. Gurina

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: ol.gurina@yandex.ru

MD, PhD, Cand. Sci. (Med.), Senior Researcher laboratory

Russian Federation, Saint Petersburg

References

  1. Алексеев В.В., Алипов А.Н., Андреев В.А., и др. Медицинские лабораторные технологии: руководство по клинической лабораторной диагностике. В 2-х томах. – М.: ГЭОТАР-Медиа, 2013. – 792 с. [Alekseev VV, Alipov AN, Andreev VA, et al. Meditsinskie laboratornye tekhnologii: rukovodstvo po klinicheskoi laboratornoi diagnostike. V 2-kh tomakh. Moscow: GEHOTAR-Media., 2013. 792 p. (In Russ.)]
  2. Глущенко В.А., Ирклиенко Е.К. Сердечно-сосудистая заболеваемость — одна из важнейших проблем здравоохранения // Медицина и организация здравоохранения. – 2019. – Т. 4. – № 1. – С. 56–63. [Glushhenko VA, Irklienko EK. Cardiovascular morbidity – one of the most vital problems of modern health care. Medicine and health care organization. 2019;4(1):56-63. (In Russ.)]
  3. Данилова Л.А., Башарина О.Б., Красникова Е.Н., и др. Справочник по лабораторным методам исследования. М.: Питер, 2003. – 733 с. [Danilova LA, Basharina OB, Krasnikova EN, et al. Spravochnik po laboratornym metodam issledovaniya. Moscow: Piter, 2003. 733 p. (In Russ.)]
  4. Кардиоваскулярная профилактика 2017. Национальные рекомендации. [Интернет]. М., 2017. – 288 с. [Kardiovaskulyarnaya profilaktika 2017. Natsional’nye rekomendatsii. [Internet]. Moscow, 2017. 288 p. (In Russ.)] Доступ по ссылке: https://scardio.ru/content/Guidelines/Cardiovascular-prof-2017.pdf
  5. Староверов И.И., Шахнович Р.М., Гиляров М.Ю., и др. Евразийские клинические рекомендации по диагностике и лечению острого коронарного синдрома с подъемом сегмента ST (ОКСпST) // Евразийский кардиологический журнал. – 2020. – № 1. – C. 4–77. [Staroverov II, Shakhnovich RM, Gilyarov MYu, et al. Eurasian clinical guidelines on diagnosis and treatment of acute coronary syndrome with st segment elevation (STEMI). Eurasian Heart Journal. 2020;(1):4-77. (In Russ.)] https://doi/org/10.38109/2225-1685-2020-1-4-77
  6. Щеглов Д.С., Василенко В.С., Авдеева М.В. Состояние клеточного и гуморального иммунитета у больных с мультифокальным атеросклеротическим поражением различных сосудистых бассейнов // Медицина: теория и практика. – 2017. – Т. 2. – № 3. – С. 3–7. [Shcheglov DS, Vasilenko VS, Avdeeva MV, et al. Cellular and humoral immunity in patients with multifocal atherosclerosis. Medicine: theory and practice. 2017;2(3):3-7. (In Russ.)]
  7. Bajraktari G, Jashari H, Ibrahimi P, et al. Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trials. Coron Artery Dis. 2018;29(3):204-215. https://doi.org/10.1097/MCA.0000000000000602
  8. Cui K, Lyu S, Song X, et al. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. Am J Cardiol. 2019;124(3):334-342. https://doi.org/10.1016/j.amjcard.2019.04.048
  9. Elgendy IY, Mahmoud AN, Kumbhani DJ, et al. Complete or culprit-only revascularization patients with multivessel coronary artery disease undergoing percutaneous coronary interven- tion for: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017;10(4):315-324. https://doi.org/10.1016/j.jcin.2016.11.047.
  10. Fioranelli M, Bottaccioli AG, Bottaccioli F, et al. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018;6(9):2031. https://doi.org/10.3389/fimmu.2018.02031
  11. George J, Mathur R, Shah AD, et al. Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients. PLoS One. 2017;12(6): e0178945. https://doi.org/10.1371/journal.pone.0178945
  12. Helwani MA, Amin A, Lavigne P, et al. Etiology of Acute Coronary Syndrome after Noncardiac Surgery. Anesthesiology. 2018;128(6):1084-1091. https://doi.org/10.1097/ALN.0000000000002107
  13. Khera AV, Kathiresan S. Is coronary atherosclerosis one disease or many? Setting realistic expectations for precision medicine. Circulation. 2017;135(11):1005-1007. https://doi.org/10.1161/CIRCULATIONAHA.116.026479
  14. Kolkailah AA, Alreshq RS, Muhammed AM, et al. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease. Cochrane Database Syst Rev. 2018;18(4): CD012318. https://doi.org/10.1002/14651858.CD012318.pub2
  15. Martins TB, Anderson JL, Muhlestein JB, et al. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol. 2006;125(6):906-913. https://doi.org/10.1309/Q3E6-KF0Q-D3U3-YL6T.
  16. Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract. 2019;8:1-11. https://doi.org/10.2147/IPRP.S133088
  17. Min X, Lu M, Tu S, et al. Serum cytokine profile in relation to the severity of coronary artery disease. Biomed Res Int. 2017;(7):1-9. https://doi.org/10.1155/2017/4013685
  18. Mirzaei H, Ferns GA, Avan A. Chapter Two – cytokines and microRNA in coronary artery disease. Adv Clin Chem. 2017;82:47-70. https://doi.org/10.1016/bs.acc.2017.06.004
  19. Moreno Velásquez I, Gajulapuri A, Leander K, et al. Serum IL8 is not associated with cardiovascular events but with all-cause mortality. BMC Cardiovasc Disord. 2019;19(1):34. https://doi.org/10.1186/s12872-019-1014-6
  20. Osman M, Khan SU, Farjo PD, et al. Meta-analysis comparing complete versus infarct-related artery revascularization in patients with ST-elevation myocardial infarction and multivessel coronary disease. Am J Cardiol. 2019;125(4):513-520. https://doi.org/10.1016/j.amjcard.2019.11.017
  21. Pimor A, Auffret V, Didier R, et al. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Arch Cardiovasc Dis. 2018;111(11):656-665. https://doi.org/10.1016/j.acvd.2017.08.005
  22. Pineda AM, Carvalho N, Gowani SA, et al. Managing multivessel coronary artery disease in patients with ST-elevation myocardial infarction: a comprehensive review. Cardiol Rev. 2017;25(4):179-188. https://doi.org/10.1097/CRD.0000000000000110.
  23. Pothineni NVK, Subramany S, Kuriakose K, et al. Infections, atherosclerosis, and coronary heart disease. Eur Heart J. 2017;38(43):3195-3201. https://doi.org/10.1093/eurheartj/ehx362
  24. Естественное движение населения в разрезе субъектов Российской Федерации за январь–декабрь 2018 года [интернет]. [Estestvennoe dvizhenie naseleniya v razreze sub"ektov Rossiiskoi Federatsii za yanvar'–dekabr' 2018 goda [internet]] Режим доступа: https://www.gks.ru/free_doc/2018/demo/edn12-18.htm. Ссылка активна на 16.06.2021.

Statistics

Views

Abstract: 95

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c) 2021 Gostimskiy V.A., Vasilenko V.S., Kurnikova E.A., Shenderov S.V., Gurina O.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies